1. Home
  2. STTK vs CULP Comparison

STTK vs CULP Comparison

Compare STTK & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STTK
  • CULP
  • Stock Information
  • Founded
  • STTK 2016
  • CULP 1972
  • Country
  • STTK United States
  • CULP United States
  • Employees
  • STTK N/A
  • CULP N/A
  • Industry
  • STTK Biotechnology: Pharmaceutical Preparations
  • CULP Textiles
  • Sector
  • STTK Health Care
  • CULP Consumer Discretionary
  • Exchange
  • STTK Nasdaq
  • CULP Nasdaq
  • Market Cap
  • STTK 56.8M
  • CULP 62.9M
  • IPO Year
  • STTK 2020
  • CULP N/A
  • Fundamental
  • Price
  • STTK $1.11
  • CULP $5.47
  • Analyst Decision
  • STTK Hold
  • CULP
  • Analyst Count
  • STTK 3
  • CULP 0
  • Target Price
  • STTK $2.00
  • CULP N/A
  • AVG Volume (30 Days)
  • STTK 172.1K
  • CULP 28.2K
  • Earning Date
  • STTK 02-27-2025
  • CULP 03-05-2025
  • Dividend Yield
  • STTK N/A
  • CULP N/A
  • EPS Growth
  • STTK N/A
  • CULP N/A
  • EPS
  • STTK N/A
  • CULP N/A
  • Revenue
  • STTK $6,435,000.00
  • CULP $222,157,000.00
  • Revenue This Year
  • STTK $313.04
  • CULP $1.94
  • Revenue Next Year
  • STTK N/A
  • CULP $10.13
  • P/E Ratio
  • STTK N/A
  • CULP N/A
  • Revenue Growth
  • STTK 382.75
  • CULP N/A
  • 52 Week Low
  • STTK $0.94
  • CULP $4.25
  • 52 Week High
  • STTK $11.76
  • CULP $6.85
  • Technical
  • Relative Strength Index (RSI)
  • STTK 44.36
  • CULP 47.67
  • Support Level
  • STTK $1.13
  • CULP $5.37
  • Resistance Level
  • STTK $1.22
  • CULP $5.59
  • Average True Range (ATR)
  • STTK 0.11
  • CULP 0.19
  • MACD
  • STTK -0.01
  • CULP -0.04
  • Stochastic Oscillator
  • STTK 15.15
  • CULP 17.54

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

About CULP Culp Inc.

Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: